WebIn Lonza Biologics' GS Gene Expression System™, recombinant protein-producing GS-CHOK1SV cell lines are generated by transfection with an expression vector encoding both GS and the protein product genes followed by selection in MSX and glutamine-free medium. MSX is required to inhibit endogenous CHO … WebL-Buthionine-(S,R)-sulfoximine is a potent and irreversible inhibitor of γ-glutamylcysteine synthetase (γGCS; Ki 100 μM) and used to deplete glutathione and sensitize cells to …
Buthionine Sulfoximine - an overview ScienceDirect Topics
WebL-Buthionine-sulfoximine (L-BSO); >= 97% TLC; This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC 1280), a biologically … WebProduct Description. L-Buthionine- (S,R)-sulfoximine is an irreversible inhibitor of γ-glutamylcysteine synthetase (K i = 25 µM). 1 It inhibits the proliferation of ZAZ and M14 melanoma cells, as well as A2780 ovarian and MCF-7 breast cancer cells (IC 50 s = 4.9, 18, 8.5, and 26.5 µM, respectively). 2 L-Buthionine- (S,R)-sulfoximine (100µM ... cafe billing management
l-Buthionine sulfoximine C8H18N2O3S - PubChem
WebCAS: 83730-53-4: Molecular Formula: C 8 H 18 N 2 O 3 S: Molecular Weight (g/mol) 222.31: MDL Number: MFCD00067000: InChI Key: KJQFBVYMGADDTQ-CVSPRKDYSA-N: Synonym: l-buthionine-sulfoximine, l-buthionine sulfoximine, 2s-2-amino-4-butylsulfonimidoyl butanoic acid, l-buthionine-s,r-sulfoximine, l-buthionine s,r … WebButhionine sulfoximine pretreatment increased the sensitivity of G361, SVK14, HaCaT, and NCTC 2544 human skin cells to SM (Simpson and Lindsay, 2005). In the endothelial cells presence of reduced glutathione improved the cell viability when exposed to SM. Pretreatment with buthionine sulfoximine, an inhibitor of glutathione synthesis, alone … WebDepletion of GSH by buthionine sulfoximine (BSO) restores the sensitivity of resistant tumors to melphalan in vitro and in vivo. In a phase I trial, each patient received two … cafe binggo